2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO20] Mini-Oral Session 20　Translational Research / Clinical Pharmacology 3（Biomarker）
【E】

Fri. Feb 18, 2022 8:20 AM - 9:10 AM Room 4 (Room A, 2F, Kyoto International Conference Center)

Chair：Hiroshi Ishiguro（Breast Oncology Service, Saitama Medical University International Medical Center），Natsuko Chiba（Department of Cancer Biology, Institute of Development, Aging and Cancer, Tohoku University）

[MO20-4] BRCA1-mediated transactivation causes resistance to PARP inhibitors without affecting homologous recombination activity

○Natsuko Chiba, Yuki Yoshino, Shino Endo (Department of Cancer Biology, IDAC, Tohoku University)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password